Search research articles
Contact Us
Filters
Showing results (171-180 of 230) with videos related to
Page
of 23
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
Yu Du, Jie Dai, Lili Mao, et al.
European Journal of Radiology
|
June 12, 2026
Feasibility of low-dose carotid CT angiography (CTA) for quantitative carotid plaque evaluation
Min Jie Zhao, Chang Sheng Zhou, Jian Rui Li, et al.
The Oncologist
|
March 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
Li Zhou, Zhiting Shao, Yiqiang Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2021
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
Bixia Tang, Jiazhi Mo, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2021
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort
Xue Bai, Michelle Kim, Gyulnara Kasumova, et al.
Nature Communications
|
November 21, 2024
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Yalei Wen, Hui Wang, Xiao Yang, et al.
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Annals of Surgical Oncology
|
May 12, 2018
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients
ChuanLiang Cui, Bin Lian, Li Zhou, et al.
Translational Oncology
|
April 14, 2019
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 23, 2018
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
Xinan Sheng, Dengfeng Cao, Jianlin Yuan, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 230) with videos related to
Sort By:
Page
of 23
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
Yu Du, Jie Dai, Lili Mao, et al.
European Journal of Radiology
|
June 12, 2026
Feasibility of low-dose carotid CT angiography (CTA) for quantitative carotid plaque evaluation
Min Jie Zhao, Chang Sheng Zhou, Jian Rui Li, et al.
The Oncologist
|
March 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
Li Zhou, Zhiting Shao, Yiqiang Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2021
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
Bixia Tang, Jiazhi Mo, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2021
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort
Xue Bai, Michelle Kim, Gyulnara Kasumova, et al.
Nature Communications
|
November 21, 2024
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Yalei Wen, Hui Wang, Xiao Yang, et al.
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Annals of Surgical Oncology
|
May 12, 2018
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients
ChuanLiang Cui, Bin Lian, Li Zhou, et al.
Translational Oncology
|
April 14, 2019
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 23, 2018
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
Xinan Sheng, Dengfeng Cao, Jianlin Yuan, et al.
Page
of 23